These are clear clinical benefits from giving G-CSF together with cytotoxic chemotherapies, but there are previous studies raising concerns that G-CSF use may promote cancer progression, and particularly metastasis, in the context of induced neutrocytosis 24, 25. This evidence concerns the gene CSF3 and cancer.